Hyperphagia in Prader-Willi syndrome

Clinical trials for Hyperphagia in Prader-Willi syndrome explained in plain language.

Never miss a new study

Get alerted when new Hyperphagia in Prader-Willi syndrome trials appear

Sign up with your email to follow new studies for Hyperphagia in Prader-Willi syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Terminated 2

New nasal spray aims to tame relentless hunger in rare genetic disorder

Symptom relief Ongoing

This Phase 3 trial tests a nasal spray called carbetocin to reduce the intense, constant hunger (hyperphagia) in people with Prader-Willi syndrome. The study involves 170 participants aged 5 to 30 and lasts 12 weeks. Caregivers will rate changes in hunger-related behaviors using …

Matched conditions: HYPERPHAGIA IN PRADER-WILLI SYNDROME

Phase 3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Jun 26, 2026 16:16 UTC

Hyperphagia in Prader-Willi syndrome

Get alerted when new Hyperphagia in Prader-Willi syndrome trials appear

New nasal spray aims to tame relentless hunger in rare genetic disorder